Explore how small molecules target RNA-protein interfaces for revolutionary medical treatments, including computational methods, case studies, and therapeutic strategies.
Explore the revolutionary development of oligonucleotide therapeutics in 1999, from the FDA approval of Vitravene to the cutting-edge research presented at the IBC Sixth International Conference.